Advertisement

Introductory Remarks

  • J. P. Colombo
Conference paper

Abstract

Screening programs for congenital disorders of amino acid metabolism were started at the beginning of the 1960s in the United States, Canada, and Europe, particularly for PKU. The term “hyperphenylalaninemia” was not yet conceived. Today we know different variants of this disorder, but they still present some problems of classification. The screening programs spread over all the continents. New fields for screening were opened, such as carbohydrate disorders, particularly galactosemia. Recently, screening for thyroid diseases was started in many programs. Several other disorders have been covered by screening programs, some of which, however, were short-lived and abandoned.

Keywords

United States Quality Control Congenital Disorder Screening Program Public Opinion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • J. P. Colombo

There are no affiliations available

Personalised recommendations